The present invention relates to a non-hormonal, biocompatible, and biodegradable intravaginal device for the delivery of spermiostatic, spermicidal and anti-infectious agents. The present invention also relates to methods of contraception using such a device, as well as the prevention and treatment
The present invention relates to a non-hormonal, biocompatible, and biodegradable intravaginal device for the delivery of spermiostatic, spermicidal and anti-infectious agents. The present invention also relates to methods of contraception using such a device, as well as the prevention and treatment of sexually transmitted diseases and vaginal infections through the application of the device.
대표청구항▼
1. An intravaginal contraceptive device, comprising: a biocompatible polymeric support structure configured to be inserted into a woman's vagina, the support structure constructed, configured and formed of materials such that the structure is capable of biocompatibly remaining in a woman's vagina fo
1. An intravaginal contraceptive device, comprising: a biocompatible polymeric support structure configured to be inserted into a woman's vagina, the support structure constructed, configured and formed of materials such that the structure is capable of biocompatibly remaining in a woman's vagina for three days without dissolving completely;the support structure impregnated with a non-hormonal composition comprising ascorbic acid in an effective amount to increase the viscosity of cervical mucus and a contraceptively effective amount of ferrous gluconate or ferrous-sulfate, the device configured and formed with biodegradable materials so that when inserted into the vagina the ascorbic acid and ferrous gluconate or ferrous sulfate are released via degradation of the biodegradable materials of the device, to contraceptively reduces sperm mobility and contraceptively increases cervical mucus to impeded sperm mobility and the device includes a releasable pH limiting component to maintain a pH in the vaginal cavity at a spermiostatic level;the support structure with the composition disposed therein constructed and formed with materials effective to break down when present within the vagina and provide sustained release of a contraceptively effective amount of the composition for three days. 2. The device of claim 1, wherein the non-hormonal composition is effective to maintain the pH in the vaginal cavity at about 5. 3. The device of claim 1, wherein the composition comprises ferrous gluconate. 4. The device of claim 1, wherein the composition comprises ferrous sulfate. 5. An intravaginal contraceptive device, comprising: a biocompatible polymeric support structure configured to be inserted into a woman's vagina, the support structure constructed, configured and formed of materials such that the structure is capable of biocompatibly remaining in a woman's vagina for 28 days without dissolving completely;the support structure impregnated with a non-hormonal composition comprising ascorbic acid in an effective amount to increase the viscosity of cervical mucus and a contraceptively effective amount of ferrous gluconate or ferrous sulfate, the device configured and formed with biodegradable materials so that when inserted into the vagina, the ascorbic acid and ferrous gluconate or ferrous sulfate are released via degradation of the biodegradable materials of the device, to contraceptively reduces sperm mobility and contraceptively increases cervical mucus to impeded sperm mobility and the device includes a releasable pH limiting component to maintain a pH n the vaginal cavity at a spermiostatic level;the support structure with the composition disposed therein constructed and formed with materials effective to break down when present within the vagina and provide sustained release of a contraceptively effective amount of the composition for 28 days. 6. The device of claim 1, wherein the composition further comprises magnesium chloride or calcium chloride. 7. The device of claim 1, wherein the support structure comprises poly-DL lactide. 8. The device of claim 1, wherein the support structure has an opening therethrough and said composition comprises a spermicidally or spermiostatically effective amount of an acid-rich polymer. 9. The device of claim 8, wherein the support structure comprises hydrogel material. 10. The device of claim 8, wherein the composition comprises ferrous gluconate. 11. The device of claim 6, wherein the support structure comprises hydrogel material. 12. The device of claim 8, wherein the acid-rich polymer comprises a polyamino acid, a polycarboxylic acid, or combinations thereof. 13. The device of claim 1, wherein the support structure has an annular shape. 14. The device of claim 13, wherein the pH limiting component is present in an effective amount to prevent the pH in a vagina from increasing in the presence of seminal fluid. 15. The device of claim 13, wherein the composition comprises a biocompatible organic acid. 16. The device of claim 13, wherein the composition comprises a polyamino acid or a polycarboxylic acid or combinations thereof. 17. The device of claim 16, wherein the device is in a ring-like configuration. 18. The device of claim 16, wherein the support structure comprises a convoluted shape. 19. An intravaginal contraceptive device, comprising: a biocompatible polymeric support structure configured to be inserted into a woman's vagina, the support structure constructed, configured and formed of materials such that the structure is capable of biocompatibly remaining in a woman's vagina for 7 days without dissolving completely;the support structure impregnated with a non-hormonal composition comprising ascorbic acid in an effective amount to increase the viscosity of cervical mucus and a contraceptively effective amount of ferrous gluconate or ferrous sulfate, the device configured and formed with biodegradable materials so that when inserted into the vagina, the ascorbic acid and ferrous gluconate or ferrous sulfate are released via degradation of the biodegradable materials of the device, to contraceptively reduces sperm mobility and contraceptively increases cervical mucus to impeded sperm mobility and the device including a releasable pH limiting component to maintain a pH in the vaginal cavity at a spermiostatic level;the support structure with the composition disposed therein is constructed and formed of materials effective to provide sustained release of said effective amount of the composition for 7 days. 20. An intravaginal contraceptive device, comprising: a biocompatible polymeric support structure configured to be inserted into a woman's vagina, the support structure constructed, configured and formed of materials such that the structure is capable of biocompatibly remaining in a woman's vagina for 16 days without dissolving completely;the support structure impregnated with a non-hormonal composition comprising ascorbic acid in an effective amount to increase the viscosity of cervical mucus and a contraceptively effective amount of ferrous gluconate or ferrous sulfate, the device configured and formed with biodegradable materials so that when inserted into the vagina, the ascorbic acid and ferrous gluconate or ferrous sulfate are released via degradation of the biodegradable materials of the device, to contraceptively reduce sperm mobility and contraceptively increases cervical mucus to impeded sperm mobility and the device including a releasable pH limiting component to maintain a pH in the vaginal cavity at a spermiostatic level;the support structure with composition disposed therein is constructed and formed of materials effective to provide sustained release of said effective amount of the composition for 16 days. 21. The device of claim 1, wherein the device comprises effective amounts of the pH limiting component to maintain a pH of about 5-6 in a vagina during the sustained release of said composition, in the presence of semenal fluid. 22. The device of claim 13, wherein the composition comprises ferrous gluconate. 23. The device of claim 1, wherein the support structure comprises hydrogel material. 24. The device of claim 1, wherein the support structure comprises at least one of dextran-maleic acid, dextran-acrylate, dextran-allyl isocyanate, polyglycolide, polylactide, co-polymers of polyglycolide or polylactide, or combinations thereof. 25. The device of claim 1, wherein the support structure comprises a plurality of layered polymer sheaths over a core. 26. The device of claim 1, wherein the support structure comprises a plurality of layered polymer sheaths that dissolve at varying rates. 27. The device of claim 1, wherein the device is effective to result in producing a pH of about 3.5 to 5.5.
Brode George L. (Bridgewater NJ) Doncel Gustavo F. (Norfolk VA) Gabelnick Henry L. (N. Bethesda MD) Kreeger Russell L. (Flemington NJ) Salensky George A. (White House Station NJ), Contraceptive compositions.
Sawan Samuel P. (Tyngsboro MA) Dollinger Harli M. (Dracut MA) Horne ; Jr. Herbert W. (Framingham MA), Contraceptive intracervical device and novel nonsystemic agents for the prevention of conception and disease.
Magruder Paul R. (Palo Alto CA) Wong Patrick S. (Hayward CA) Theeuwes Felix (Los Altos CA) Guittard George V. (Cupertino CA), Hydrogel formulation for administering non-steroidal drugs.
Cohen Robert S. (New York NY) Pierce James M. (Coral Gables FL) Kinsey William H. (Coral Gables FL), Intra-vaginal device and method for sustained drug release.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.